How much does it cost to buy a box of Fostamatinib in 2025?

Fostamatinib (Fostamatinib) is an oral small molecule inhibitor that exerts therapeutic effects by selectively targeting spleen tyrosine kinase (SYK) and is mainly used in the regulation of autoimmune diseases. As a second-generation spleen tyrosine kinase inhibitor, its core indication is adult patients with chronic immune thrombocytopenic purpura (ITP). It is especially suitable for refractory cases that have insufficient response or intolerance to corticosteroids, intravenous immunoglobulin (IVIg) or splenectomy.

In terms of clinical mechanism, fotantinib inhibits the phagocytosis of platelets and immune complexes by macrophages by blockingSYK-mediated Fcγ receptor signaling pathway, thereby reducing excessive platelet destruction and increasing the platelet count in peripheral blood. The U.S. Food and Drug Administration (FDA) approved its marketing in 2018, becoming the world's first SYK inhibitor approved for ITP. In addition to ITP, the potential efficacy of this drug in rheumatoid arthritis, IgA nephropathy and certain hematological malignancies (such as diffuse large B-cell lymphoma) is also in the research stage, but it has not yet received formal indication expansion.

Fotantinib currently has two common specifications: 100mg*60 tablets and 150mg*60 tablets. Since its original research version has not yet been launched in China, the specific price and medical insurance policy are still unclear. In foreign markets, the original German version is available for purchase, priced between 20,000 and 40,000 yuan (the price may fluctuate due to exchange rate effects), and is generally relatively expensive. In addition, there are currently no generic versions of fotantinib available for sale overseas. If more information is needed, patients can consult Yaode Medical Consultants to learn about overseas drug prices and related information.

Reference materials:https://medlineplus.gov/druginfo/meds/a618025.html